The Only Cannabis Stock I’d Buy Today

If you were to say that Aphria Inc. (TSX:APHA)(NYSE:APHA) was going to be my top cannabis stock a year ago, I would have laughed. A year ago, the situation was very different for this top pot stock. The company was mired in controversy, with the word “acquisition” even being thrown around now and again. Today, however, with the COVID-19 pandemic striking all…

Read More

3 Smoking-Hot Cannabis 2.0 Stocks That Could Grow Tenfold Over the Next Decade

The Canadian cannabis market shifted into a new gear with the launch of Cannabis 2.0 products in late 2019. Cannabis 2.0 products include edibles, extracts, and vaporizers. This segment of the cannabis market carries with it much higher profit margins than dried flower products do. Companies and investors are thus cautiously optimistic about a second green rush occurring. These three…

Read More

This Pot Stock Could Go From $400 Million to $4 Billion

Hexo Corp (TSX:HEXO)(NYSE:HEXO) isn’t a big pot stock. It’s worth only $400 million. Many of its competitors are worth several billion dollars. But if you’re looking for big upside, this is the stock for you. It all comes down to strategy. From the start, Hexo took a unique route. The rest of the industry followed a traditional path. This is…

Read More

Is Namaste Technologies’ Stock a Buy After Reporting Record Quarterly Revenue?

It once aspired to be “the Amazon of cannabis,” but e-commerce focused marijuana stock Namaste Technologies (TSXV:N) has taken on a manufacturing-based growth strategy that’s beginning to yield impressive results. The company has shaken off its drama-filled past. Operations have returned to strong sequential quarterly sales growth. Actually, the company reported record quarterly revenue in last week’s earnings release. Should…

Read More

This $400 Million Pot Stock Can Go to $2 Billion

Molson Coors Canada Inc. (TSX:TPX.B)(NYSE:TAP) is one of the most popular brands in Canada. Its market cap exceeds $10 billion, giving it plenty of liquidity to pursue long-term growth opportunities. If you look closely, it’s clear that Molson is about to send shares of one pot stock soaring. It’s important to note that Molson hasn’t entered the marijuana industry directly.…

Read More

Buy This 1 Pot Stock for a COVID-19 Breakthrough

Pot stock investors: watch this space. Cannabis stocks could get a second wind, as researchers investigate whether cannabis could be an effective treatment for COVID-19. Indeed, as the coronavirus market searches for solutions, cannabis could take centre stage. But is Aphria (TSX:APHA)(NASDAQ:APHA) the best stock to buy for this eventuality? Let’s discuss this compelling new thesis. Researchers are getting cannabinoid…

Read More

Canopy (TSX:WEED) and Aurora (TSX:ACB): Two Industry Juggernauts With Very Different Strategies

As the Canadian cannabis space has begun to enter a new phase, it is interesting to look back at how we got here. An initial frantic arms race to accumulate as much production capacity as possible eventually gave way to the reality that demand would be a lot slower to migrate to the legal market than market participants had hoped.…

Read More

Sell Warning: This One Stock Will Kill Your Portfolio

Growth investors may be enticed to consider various cannabis stocks today on stock price alone. One must think that if a group of stocks loses the vast majority of their value in a short period, value is beneath the surface. I’m going to explain why I believe this is a dangerous perspective. Even the best cannabis stocks are in trouble…

Read More

TFSA Investors: 3 Reasons to Buy Aphria Stock Today

Cannabis firm Aphria’s (TSX:APHA)(NASDAQ:APHA) stock price rallied to close 9% higher on Monday after W. Andrew Carter, a respected equity analyst at Stifel Financial, upgraded the top marijuana stock from a Hold to a Buy and increased his price target. The analyst’s US$5.90 new price target on APHA shares implied a 26% upside from the company’s previous share price at…

Read More